NAT1 and breast cancer: In the present study, we utilized CRISPR/Cas9 to investigate the effects of NAT1 knockout (KO) on endogenous AcCoA levels and the cell growth properties in three human breast cancer cell lines that originate from separate pleural effusions of different malignant breast cancer patients frequently used in breast cancer research.